Specific EGFR mutations predict treatment outcome of stage IIIB/IV patients with chemotherapy-naive non-small-cell lung cancer receiving first-line gefitinib monotherapy.

Yang CH, Yu CJ, Shih JY, Chang YC, Hu FC, Tsai MC, Chen KY, Lin ZZ, Huang CJ, Shun CT, Huang CL, Bean J, Cheng AL, Pao W, Yang PC
J Clin Oncol. 2008 26 (16): 2745-53

PMID: 18509184 · DOI:10.1200/JCO.2007.15.6695

MeSH Terms (17)

Adult Aged Antineoplastic Agents Carcinoma, Non-Small-Cell Lung Female Gefitinib Gene Deletion Genes, erbB-1 Genes, ras Humans Lung Neoplasms Male Middle Aged Mutation Predictive Value of Tests Quinazolines Survival Analysis

Connections (1)

This publication is referenced by other Labnodes entities: